Literature DB >> 24371076

High-affinity Rb binding, p53 inhibition, subcellular localization, and transformation by wild-type or tumor-derived shortened Merkel cell polyomavirus large T antigens.

Sophie Borchert1, Manja Czech-Sioli, Friederike Neumann, Claudia Schmidt, Peter Wimmer, Thomas Dobner, Adam Grundhoff, Nicole Fischer.   

Abstract

UNLABELLED: Interference with tumor suppressor pathways by polyomavirus-encoded tumor antigens (T-Ags) can result in transformation. Consequently, it is thought that T-Ags encoded by Merkel cell polyomavirus (MCPyV), a virus integrated in ∼90% of all Merkel cell carcinoma (MCC) cases, are major contributors to tumorigenesis. The MCPyV large T-Ag (LT-Ag) has preserved the key functional domains present in all family members but has also acquired unique regions that flank the LxCxE motif. As these regions may mediate unique functions, or may modulate those shared with T-Ags of other polyomaviruses, functional studies of MCPyV T-Ags are required. Here, we have performed a comparative study of full-length or MCC-derived truncated LT-Ags with regard to their biochemical characteristics, their ability to bind to retinoblastoma (Rb) and p53 proteins, and their transforming potential. We provide evidence that full-length MCPyV LT-Ag may not directly bind to p53 but nevertheless can significantly reduce p53-dependent transcription in reporter assays. Although early region expression constructs harboring either full-length or MCC-derived truncated LT-Ag genes can transform primary baby rat kidney cells, truncated LT-Ags do not bind to p53 or reduce p53-dependent transcription. Interestingly, shortened LT-Ags exhibit a very high binding affinity for Rb, as shown by coimmunoprecipitation and in vitro binding studies. Additionally, we show that truncated MCPyV LT-Ag proteins are expressed at higher levels than those for the wild-type protein and are able to partially relocalize Rb to the cytoplasm, indicating that truncated LT proteins may have gained additional features that distinguish them from the full-length protein. IMPORTANCE: MCPyV is one of the 12 known polyomaviruses that naturally infect humans. Among these, it is of particular interest since it is the only human polyomavirus known to be involved in tumorigenesis. MCPyV is thought to be causally linked to MCC, a rare skin tumor. In these tumors, viral DNA is monoclonally integrated into the genome of the tumor cells in up to 90% of all MCC cases, and the integrated MCV genomes, furthermore, harbor signature mutations in the so-called early region that selectively abrogate viral replication while preserving cell cycle deregulating functions of the virus. This study describes comparative studies of early region T-Ag protein characteristics, their ability to bind to Rb and p53, and their transforming potential.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24371076      PMCID: PMC3957953          DOI: 10.1128/JVI.02916-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

1.  Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors.

Authors:  Masahiro Shuda; Reety Arora; Hyun Jin Kwun; Huichen Feng; Ronit Sarid; María-Teresa Fernández-Figueras; Yanis Tolstov; Ole Gjoerup; Mahesh M Mansukhani; Steven H Swerdlow; Preet M Chaudhary; John M Kirkwood; Michael A Nalesnik; Jeffrey A Kant; Lawrence M Weiss; Patrick S Moore; Yuan Chang
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

2.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

3.  Monoclonal antibodies specific for simian virus 40 tumor antigens.

Authors:  E Harlow; L V Crawford; D C Pim; N M Williamson
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

4.  Structural basis for the inactivation of retinoblastoma tumor suppressor by SV40 large T antigen.

Authors:  H Y Kim; B Y Ahn; Y Cho
Journal:  EMBO J       Date:  2001-01-15       Impact factor: 11.598

Review 5.  T antigens of simian virus 40: molecular chaperones for viral replication and tumorigenesis.

Authors:  Christopher S Sullivan; James M Pipas
Journal:  Microbiol Mol Biol Rev       Date:  2002-06       Impact factor: 11.056

Review 6.  One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.

Authors:  J Fogh; J M Fogh; T Orfeo
Journal:  J Natl Cancer Inst       Date:  1977-07       Impact factor: 13.506

7.  Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis.

Authors:  Xavier Sastre-Garau; Martine Peter; Marie-Françoise Avril; Hélène Laude; Jérôme Couturier; Flore Rozenberg; Anna Almeida; Françoise Boitier; Agnès Carlotti; Benoît Couturaud; Nicolas Dupin
Journal:  J Pathol       Date:  2009-05       Impact factor: 7.996

8.  Cyclin mRNA stability does not vary during the cell cycle.

Authors:  K Leigh Eward; Matthew N Van Ert; Maureen Thornton; Charles E Helmstetter
Journal:  Cell Cycle       Date:  2004-08-17       Impact factor: 4.534

9.  Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas.

Authors:  Klaus J Busam; Achim A Jungbluth; Natasha Rekthman; Daniel Coit; Melissa Pulitzer; Jason Bini; Reety Arora; Nicole C Hanson; Jodie A Tassello; Denise Frosina; Patrick Moore; Yuan Chang
Journal:  Am J Surg Pathol       Date:  2009-09       Impact factor: 6.394

Review 10.  Oncogenic transformation by BK virus and association with human tumors.

Authors:  Mauro Tognon; Alfredo Corallini; Fernanda Martini; Massimo Negrini; Giuseppe Barbanti-Brodano
Journal:  Oncogene       Date:  2003-08-11       Impact factor: 9.867

View more
  48 in total

Review 1.  Immune evasion mechanisms and immune checkpoint inhibition in advanced merkel cell carcinoma.

Authors:  Dirk Schadendorf; Paul Nghiem; Shailender Bhatia; Axel Hauschild; Philippe Saiag; Lisa Mahnke; Subramanian Hariharan; Howard L Kaufman
Journal:  Oncoimmunology       Date:  2017-08-31       Impact factor: 8.110

Review 2.  Large T and small T antigens of Merkel cell polyomavirus.

Authors:  Justin A Wendzicki; Patrick S Moore; Yuan Chang
Journal:  Curr Opin Virol       Date:  2015-02-11       Impact factor: 7.090

Review 3.  Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC.

Authors:  Jürgen C Becker; Andreas Stang; Axel Zur Hausen; Nicole Fischer; James A DeCaprio; Richard W Tothill; Rikke Lyngaa; Ulla Kring Hansen; Cathrin Ritter; Paul Nghiem; Christopher K Bichakjian; Selma Ugurel; David Schrama
Journal:  Cancer Immunol Immunother       Date:  2017-11-30       Impact factor: 6.968

Review 4.  The Biology and Clinical Features of Cutaneous Polyomaviruses.

Authors:  Khang D Nguyen; Bahir H Chamseddin; Clay J Cockerell; Richard C Wang
Journal:  J Invest Dermatol       Date:  2018-11-22       Impact factor: 8.551

Review 5.  Molecular Mechanisms of Merkel Cell Polyomavirus Transformation and Replication.

Authors:  Wei Liu; Jianxin You
Journal:  Annu Rev Virol       Date:  2020-06-30       Impact factor: 10.431

Review 6.  Merkel Cell Carcinoma in the Age of Immunotherapy: Facts and Hopes.

Authors:  Aric Colunga; Thomas Pulliam; Paul Nghiem
Journal:  Clin Cancer Res       Date:  2017-12-07       Impact factor: 12.531

7.  Phosphorylation of Merkel cell polyomavirus large tumor antigen at serine 816 by ATM kinase induces apoptosis in host cells.

Authors:  Jing Li; Jason Diaz; Xin Wang; Sabrina H Tsang; Jianxin You
Journal:  J Biol Chem       Date:  2014-12-05       Impact factor: 5.157

Review 8.  Merkel cell polyomavirus infection and Merkel cell carcinoma.

Authors:  Wei Liu; Margo MacDonald; Jianxin You
Journal:  Curr Opin Virol       Date:  2016-08-10       Impact factor: 7.090

9.  HTLV-1 bZIP factor protein targets the Rb/E2F-1 pathway to promote proliferation and apoptosis of primary CD4(+) T cells.

Authors:  A Kawatsuki; J-I Yasunaga; Y Mitobe; P L Green; M Matsuoka
Journal:  Oncogene       Date:  2016-01-25       Impact factor: 9.867

Review 10.  Merkel cell polyomavirus and Merkel cell carcinoma.

Authors:  James A DeCaprio
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.